Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (271-280 of 443) with videos related to

Pageof 45
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Blood Advances|January 9, 2023
Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT studyJoshua A Fein, Roni Shouval, Jacques-Emmanuel Galimard, et al.
Journal of Hematology & Oncology|October 22, 2018
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCFlorent Malard, Myriam Labopin, Christina Cho, et al.
Cancer|December 2, 2016
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Norbert-Claude Gorin, Myriam Labopin, Tomasz Czerw, et al.
British Journal of Haematology|June 26, 2014
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow TransplantationLuciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, et al.
Journal of Hematology & Oncology|September 1, 2018
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabineFederica Giannotti, Myriam Labopin, Roni Shouval, et al.
Hemasphere|October 23, 2024
Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemiaMarion Larue, Myriam Labopin, Thomas Schroeder, et al.
American Journal of Hematology|August 31, 2024
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationFrédéric Baron, Myriam Labopin, Jurjen Versluis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2023
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, et al.
Haematologica|August 24, 2019
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationKazimierz Halaburda, Myriam Labopin, Audrey Mailhol, et al.
Pageof 45

Showing results (271-280 of 443) with videos related to

Sort By:
Pageof 45
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Blood Advances|January 9, 2023
Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT studyJoshua A Fein, Roni Shouval, Jacques-Emmanuel Galimard, et al.
Journal of Hematology & Oncology|October 22, 2018
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCFlorent Malard, Myriam Labopin, Christina Cho, et al.
Cancer|December 2, 2016
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Norbert-Claude Gorin, Myriam Labopin, Tomasz Czerw, et al.
British Journal of Haematology|June 26, 2014
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow TransplantationLuciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, et al.
Journal of Hematology & Oncology|September 1, 2018
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabineFederica Giannotti, Myriam Labopin, Roni Shouval, et al.
Hemasphere|October 23, 2024
Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemiaMarion Larue, Myriam Labopin, Thomas Schroeder, et al.
American Journal of Hematology|August 31, 2024
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationFrédéric Baron, Myriam Labopin, Jurjen Versluis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2023
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, et al.
Haematologica|August 24, 2019
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationKazimierz Halaburda, Myriam Labopin, Audrey Mailhol, et al.
Pageof 45